For 30+ years Ionis has been the leader in RNA-targeted therapy, pioneering new markets & changing standards of care with its novel antisense technology. Ionis has developed 3 currently marketed medicines & has a premier late-stage pipeline. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision to become the leader in genetic medicine, utilizing a multi-platform approach to discover, develop and deliver life-transforming therapies.